baber/WOPTO huggingface dataset:
Patent MX-2019012213-A (MX)
Title: Coverage area adjustment to adapt satellite communications.
Inventor: DONALD RUNYON
IPC: H01Q19/17
Filed: 2017-04-10
Abstract: The described features generally relate to adjusting a native antenna pattern of a satellite to adapt communications via the satellite. For example, a communications satellite may include an antenna having a feed array assembly, a reflector, and a linear actuator coupled between the feed array assembly and the reflector. The feed array assembly may have a plurality of feeds for communicating signals associated with a communications service, and the reflector may be configured to reflect the signals transmitted between the feed array assembly and one or more target devices. The linear actuator may have an adjustable length, or otherwise provide an adjustable position between the feed array assembly and the reflector. By adjusting the position of the feed array assembly relative to the reflector, the communications satellite may provide a communications service according to a plurality of native antenna patterns.
Patent MX-2019013623-A (MX)
Title: Coupler for split-boom power tool.
Inventor: HOFFMAN RONALD J
IPC: A01D34/00
Filed: 2019-03-01
Abstract: EMPTY
Patent MX-2019013700-A (MX)
Title: Compositions and methods for the treatment of complications and disorders relating to von willebrand factor.
Inventor: JAMES C GILBERT
IPC: A61K31/7088
Filed: 2018-05-18
Abstract: The present invention provides VWF protective agents, including aptamers and antibodies for the treatment and or amelioration of complications or disorders arising from aberrant binding or function of VWF.
Patent MX-2020002070-A (MX)
Title: Soluble interferon receptors and uses thereof.
Inventor: JAMES ARTHUR POSADA
IPC: C07K14/715
Filed: 2018-08-22
Abstract: The present disclosure provides soluble interferon receptors. The methods of the disclosure can be used to treat or prevent a condition associated with an abnormal immune response.
Patent MX-2020002288-A (MX)
Title: Production method for acidic xylooligosaccharide, and acidic xylooligosaccharide.
Inventor: ISHIKAWA KOTARO
IPC: C13K13/00
Filed: 2017-08-31
Abstract: The present invention provides a reduced-cost production method for an acidic xylooligosaccharide, the production method including a step for depolymerizing a plant-derived starting material and a deacetylation step for adding a base to a solution of the product of the depolymerization step to make the pH at least 11. The present invention also provides an acidic xylooligosaccharide that has an acetyl group content of 0-5.0 mass%. The acidic xylooligosaccharide that has an acetyl group content of 0-5.0 mass% can be used as a starting material to produce pentosan polysulfate in high yields.
Patent MX-2020002419-A (MX)
Title: Writing instrument comprising two concentric writing tips.
Inventor: ROLION FRANCK
IPC: B43K1/06
Filed: 2018-09-17
Abstract: The invention relates to a writing instrument (10) comprising a housing (12) extending in a longitudinal direction (L) and having a radial direction, the writing instrument (10) comprising a first concentric writing tip (20) and a second concentric writing tip (22), the second writing tip (22) being arranged around the first writing tip (20), each writing tip being received in the housing (12) and being able to assume a position of use, wherein the writing tip protrudes from the housing (12), the housing (12) comprising, at a longitudinal end, a deformable nose (16) at least in the radial direction, the deformable nose (16) comprising at least one slit extending in the longitudinal direction, the deformable nose (16) not being deformed when only the first writing tip (20) is in the position of use and the deformable nose (16) being deformed when the second writing tip (22) is in the position of use and the deformable nose (16) comprising an outlet opening for the first and second writing tips, the diameter of the outlet opening being greater than the diameter of the first writing tip and smaller than the diameter of the second writing tip.
Patent MX-2020002903-A (MX)
Title: Method of enhancing rna expression in a cell.
Inventor: BEISSERT TIM
IPC: C12N5/074
Filed: 2018-09-11
Abstract: The present invention describes a virus-derived factor which when provided to cells, e.g., by transfecting the cells with RNA encoding the virus-derived factor, enhances expression of RNA encoding a peptide or protein in the cells. In particular, the virus- derived factor enhances survival of cells, in particular when transfected repetitively with RNA, and reduces an IFN response of cells to transfected RNA. Accordingly, the present invention provides methods and means for enhancing expression of RNA in cells. The cells are preferably transfected with the RNA.
Patent MX-2020004280-A (MX)
Title: Non-invasive substance analysis.
Inventor: MÄNTELE WERNER
IPC: A61B5/145
Filed: 2016-12-16
Abstract: The invention relates to a method and to a system for analyzing a substance (100). The method comprises the following steps: arranging an optical medium (10) on a substance surface, such that at least one region of the surface (12) of the optical medium (10) is in contact with the substance surface; emitting an excitation light beam having an excitation wavelength through the region of the surface (12) of the optical medium (10), which is in contact with the substance surface, to the substance surface; emitting a measurement light beam through the optical medium (10) to the region of the surface (12) of the optical medium (10), which is in direct contact with the substance surface, such that the measurement light beam and the excitation light beam overlap on the interface of the optical medium (10) and of the substance surface, on which the measurement light beam is reflected; direct or indirect detecting of a deflection of the reflected measurement light beam in dependence on the wavelength of the excitation light beam; and analyzing the substance (100) based on the detected deflection of the measurement light beam in dependence on the wavelength of the excitation light beam.
Patent MX-2020005952-A (MX)
Title: Use of mir101 or mir128 in the treatment of seizure disorders.
Inventor: DURING MATTHEW
IPC: C12N15/113
Filed: 2018-12-06
Abstract: Methods of treating a seizure disorder in a patient in need thereof are provided which include delivering to the patient an effective amount of a composition that increases the level of microRNA-101 molecules in brain cells of the patient. Methods of treating a seizure disorder in a patient in need thereof are provided which include delivering to the patient an effective amount of a composition that increases the level of microRNA-128 molecules in brain cells of the patient. Methods of treating a seizure disorder in a patient in need thereof are provided which include administering a vector encoding microRNA-101, pri-miR101 or pre-miR101 to the patient. Methods of treating a seizure disorder in a patient in need thereof are provided which include administering a vector encoding microRNA-128, pri-miR128 or pre-miR128 to the patient. In embodiments, increased levels of microRNA-101 and/or microRNA-128 cause improvement in one or more symptoms of the seizure disorder.
Patent MX-2020006040-A (MX)
Title: Intermediates for optically active piperidine derivatives and preparation methods thereof.
Inventor: LEE HYUK WOO
IPC: C07D211/74
Filed: 2018-12-07
Abstract: A preparation method according to the present invention makes it possible to industrially produce large amounts of highly pure optically active tert-butyl 3-methyl-4-oxopiperidine-1-carboxylate in high yield by use of commercially available reagents and solvents. In addition, the use of novel intermediates according to the present invention makes it possible to produce highly pure optically active tert-butyl 3-methyl-4-oxopiperidine-1-carboxylate in high yield.
Patent MX-2020008238-A (MX)
Title: Post-operative monitoring via patient reported outcomes.
Inventor: STERNER JEANETTE
IPC: G16H40/20
Filed: 2019-02-13
Abstract: Methods and systems for managing patient health data are provided. A patient data tracking system is provided that aggregates patient data to create one or more patient data sets. The system analyzes and/or sorts the patient data set(s) to selectively provide information to different entities. As one example, the system can generate a benchmark for one or more patient outcomes from the aggregate patient data, and the aggregate benchmark(s) can be compared to patient outcomes for a patient population, i.e., a subset of the aggregate patient data, to help a physician and/or healthcare organization monitor patient outcomes, develop treatment protocols for a patient population, or the like. Further, the system may generate one or more notifications to a caregiver based on patient outcomes, which can enable proactive intervention and follow-up with the patient and thereby help improve patient care and outcomes.
Patent MX-2021002605-A (MX)
Title: Anti-cxcl13 antibodies for treating autoimmune diseases and cancer.
Inventor: YANG QIUMEI
IPC: C07K16/24
Filed: 2019-09-18
Abstract: Provided are antibodies or fragments thereof having binding specificity to the human chemokine (C-X-C motif) ligand 13 (CXCL 13) protein. In various examples, the antibodies or fragments thereof include a VH and VL CDRs as disclosed herein, or variants thereof. Methods of using the antibodies or fragments thereof for treating autoimmune diseases and disorders are also provided.
Patent MX-2021004401-A (MX)
Title: Non-aqueous crosslinkable composition with improved appearance.
Inventor: DE WOLF ELWIN
IPC: C08G18/73
Filed: 2019-11-05
Abstract: The present invention relates to a polyol component comprising a1) a polyol having a weight averaged molecular weight Mw of from 1,000 to 4,000 Dalton, a number averaged molecular weight Mn of from 600 to 2,500 Dalton, an OH value between 80 and 300 mg KOH / g of resin and a glass transition temperature Tg of from -10 to 90 Â°C, and a2) between 0.1 and 10 % by weight of polyurea product as rheological agent, as well as it use in a crosslinkable composition especially suitable for clear coat applications.
Patent MX-2021004687-A (MX)
Title: Neutralizing anti-influenza a antibodies and uses thereof.
Inventor: LANZAVECCHIA ANTONIO
IPC: A61P31/16
Filed: 2016-03-30
Abstract: The invention relates to antibodies and binding fragments thereof that are capable of binding to influenza A virus hemagglutinin and neutralizing at least one group 1 subtype and at least 1 group 2 subtype of influenza A virus. In one embodiment, an antibody or binding fragment according to the invention is capable of binding to and/or neutralizing one or more influenza A virus group 1 subtypes selected from H1, H2, H5, H6, H8, H9, H11, H12, H13, H16 and H17 and variants thereof and one or more influenza A virus group 2 subtype selected from H3, H4, H7, H1 0, H14 and H15 and variants thereof.
Patent MX-2021006336-A (MX)
Title: Aerosol-generating system comprising venturi element.
Inventor: EMMETT ROBERT
IPC: A24D3/18
Filed: 2019-12-04
Abstract: The invention relates to an aerosol-generating system comprising an aerosol-forming substrate and a venturi element, wherein the venturi element comprises an airflow channel, wherein the airflow channel comprises an inlet portion, a central portion and an outlet portion, wherein the inlet portion is configured converging towards the central portion and the outlet portion is configured diverging from the central portion and wherein one or both of: the inlet portion is configured converging towards the central portion with an inlet angle of between 1° and 20°, and the outlet portion is diverging from the central portion with an outlet angle of between 2° and 10°.
Patent MX-2021007052-A (MX)
Title: Toilet assembly.
Inventor: VISH RONALD J
IPC: A47K13/26
Filed: 2019-12-16
Abstract: A toilet assembly (100) includes a toilet (10) with a bowl (54), a rim (56) surrounding the bowl (54), and a water inlet pipe (16) extending upward from a rear (50) of the toilet (10), a toilet seat (14) that rests on the rim (56) and has an opening (62) positioned above the bowl (54), and an attachment (30) connected to the inlet pipe (16) and the toilet seat (14). The attachment (30) includes a coupling (32) engaging the inlet pipe (16) and a hinge connection (36) connected to the coupling (32), where the seat (14) is pivotably connected to the hinge connection (36) of the attachment (30) to pivotably mount the seat (14) on the toilet (10), such that the seat (14) is pivotable about the hinge connection (36) between a raised position and a lowered position. The coupling (32) engages the inlet pipe (16) such that the hinge connection (36) is positioned and connected to the seat (14) at a location spaced upward from the top surface (22) of the rear (50) of the toilet (10).
Patent MX-2021007150-A (MX)
Title: Pharmaceutical compound, the method of its making and use as medicinal agent.
Inventor: REDER ANATOLIY
IPC: C07D243/14
Filed: 2019-01-30
Abstract: The invention relates to a crystalline form of the Compound (I), wherein the crystalline form displays its strongest reflection, stated as a 2Î value, at 25±0.2°, in an X-ray powder diffraction pattern. The invention also relates to a method of making this crystalline form, as well as pharmaceutical compositions comprising thereof. Furthermore, the invention relates to methods of using this crystalline form as a medicament and in the treatment of pain.
Patent MX-2021011118-A (MX)
Title: Macrocyclic azolopyridine derivatives as eed and prc2 modulators.
Inventor: EFREMOV IVAN VIKTOROVICH
IPC: A61P35/00
Filed: 2020-03-13
Abstract: The invention relates to modulators of Embryonic Ectoderm Development (EED) and/or Polycomb Repressive Complex 2 (PRC2) useful in the treatment of disorders and diseases associated with EEC and PRC2, being macrocyclic azolopyridine derivatives and compositions thereof of Formula (I), or a pharmaceutically acceptable salt, prodrug, solvate, hydrate, enantiomer, isomer, or tautomer thereof, wherein X<sub>1</sub>, X<sub>2</sub>, X<sub>3</sub>, A<sub>1</sub>, A<sub>2</sub>, Y, R<sub>1</sub>, R<sub>2</sub>, R<sub>3</sub>, and R<sub>4</sub> are as described herein.
Patent MX-2021011993-A (MX)
Title: Coaxial cable processing device and method.
Inventor: WANG ZHEN
IPC: H01B11/18
Filed: 2021-09-30
Abstract: The present invention relates to a coaxial cable processing device and a method for processing a coaxial cable. The coaxial cable processing device has a first clamping member provided with a first clamping part; a second clamping member provided with a second clamping part which is opposite to the first clamping part; and a first driving device configured to drive the first clamping member and/or the second clamping member to make the first clamping part and the second clamping part move towards or away from each other in a straight line. When the first clamping member and the second clamping member move towards each other and clamp a shielding layer of a coaxial cable, the first clamping part and the second clamping part respectively surround a part of the coaxial cable in a circumferential direction and apply radial pressure on the shielding layer to flare it. The coaxial cable processing device of the present invention can replace manual operation and has high degree of automation.
Patent MX-2022001953-A (MX)
Title: Method and apparatus for improved packet detection rule provision.
Inventor: YANG YONG
IPC: H04W80/10
Filed: 2020-08-10
Abstract: Various embodiments of the present disclosure provide methods and apparatuses for improved packet detection rule provision. A method performed by a first network entity comprises: transmitting packet detection information, PDI, to a second network entity, wherein the PDI indicates information on one or more traffic endpoints on which packets are to be detected.
Patent MX-2022002085-A (MX)
Title: Image decoding method and device therefor.
Inventor: KIM SEUNGHWAN
IPC: H04N19/124
Filed: 2020-08-20
Abstract: A method by which a decoding device decodes an image, according to the present document, comprises the steps of: acquiring image information; and generating a reconstruction picture on the basis of the image information.
Patent MX-2022003747-A (MX)
Title: Packet forwarding method, device and system.
Inventor: CHEN LIHAO
IPC: H04J3/06
Filed: 2020-09-17
Abstract: Provided are a packet forwarding method, device and system. The method comprises: a first network device receives a first message sent by a second network device via a second egress port of the second network device, the first message being used to measure a phase difference, the phase difference being a phase difference between a switching time of one first buffer among multiple first buffers of a first egress port of the first network device and a switching time of one second buffer among multiple second buffers of the second egress port of the second network device when taking link delay into account; the first network device determines the phase difference according to the first message; the first network device schedules a second data packet sent via the first egress port according to the phase difference. Thus, the first network device and the second network device realize queuing and forwarding of data packets without relying on time synchronization.
Patent MX-2022005879-A (MX)
Title: Treatment and prevention of dengue disease.
Inventor: NEYTS JOHAN
IPC: A61K31/404
Filed: 2020-11-13
Abstract: The present invention relates to the use of substituted indole derivatives and substituted indoline derivatives in the manufacture of a medicament for the treatment of dengue disease in an individual infected by dengue virus or the prevention of dengue disease in an individual at risk of being infected by Dengue virus. The invention further provides a method for the treatment or the prevention of dengue in an individual at risk of being infected by Dengue virus.
Patent MX-2022007117-A (MX)
Title: Antibody with binding specificity for human il-13.
Inventor: ADAMS RALPH
IPC: C07K16/24
Filed: 2020-12-18
Abstract: The invention relates to antibody molecules having specificity for antigenic determinants of human IL-13, therapeutic uses of the antibody molecules and methods for producing the antibody molecules.The invention relates to antibody molecules having specificity for antigenic determinants of human IL-13, therapeutic uses of the antibody molecules and methods for producing the antibody molecules. The present invention relates to a multi-specific antibody having specificity for human IL-13, human IL-17A and/or human IL-17F. The invention further relates to methods for producing the multi-specific antibody and to its therapeutic use for the treatment of atopic dermatitis and other diseases.
Patent MX-2022008950-A (MX)
Title: S1p receptor modulators for treating multiple sclerosis.
Inventor: HIESTAND PETER C
IPC: A61K31/137
Filed: 2008-12-16
Abstract: The present invention relates uses of an S1 P receptor modulator such as 2-substituted 2- amino- propane-1,3-diol or 2-amino-propanol derivatives, e. g. a compound comprising a group of formula (X) for the treatment or prevention of neo-angiogenesis associated with a demyelinating disease, e.g. multiple sclerosis.
Patent MX-2022009495-A (MX)
Title: Characteristics of meat products.
Inventor: KAYSER KEVIN J
IPC: C12N5/071
Filed: 2021-02-04
Abstract: The present disclosure provides methods and compositions useful for the production of slaughter-free meat products, and the characterizations of the same. The slaughter-free meat products contain several points of distinction when compared to conventional meat procured by harvesting the tissue of a dead animal. Such points of distinction include, but are not limited to, significantly reduced or substantially no: steroid hormones, antibiotics, or microbial contamination; lower fat content; no vasculature; and extended shelf life both at room temperature and when refrigerated.
Patent MX-2022012834-A (MX)
Title: Torque vectoring for utility vehicles.
Inventor: ZURBRUEGG RONALD
IPC: B60K17/02
Filed: 2021-04-16
Abstract: Disclosed is a utility vehicle comprising a first front ground-engaging member; a first axle operably coupled to the first front ground-engaging member; a second front ground-engaging member; a second axle operably coupled to the second front ground-engaging member and being axially aligned with the first axle; and at least one rear ground-engaging member. The utility vehicle further comprises a torque altering unit operably coupled to at least one of the first front ground-engaging member, the second front ground-engaging member, or the at least one rear ground-engaging member. Additionally, the utility vehicle comprises a control system configured to independently control torque output at each of the first front ground-engaging member, the second front ground-engaging member, and the at least one rear ground-engaging member.
Patent MX-2022012873-A (MX)
Title: Method to create functional coatings on magnesium.
Inventor: HOU FENGYAN
IPC: C25D11/30
Filed: 2021-04-23
Abstract: In example implementations, a method for producing a coating is provided. The method includes placing a magnesium substrate into an anodizing bath, applying a voltage for a first amount of time to form a micro-porous anodizing layer having a thickness of between (1) to (50) microns on the magnesium substrate, placing the magnesium substrate with the micro-porous anodizing layer in plating bath, wherein the plating bath comprises a metal and a complexing agent with a pH between (8) and (14), applying a first current to the plating bath for a second amount of time to form an interlock layer on the micro-porous anodizing layer, and applying a second current to the plating bath for a third amount of time to form a coating on the interlock layer.
Patent MX-2022015552-A (MX)
Title: Prevention, reduction, or amelioration of old person smell.
Inventor: WANG YING
IPC: A61K8/362
Filed: 2021-06-09
Abstract: The various aspects presented herein relate to methods and compositions for the reduction, prevention, and/or inhibition of old person smell.
Patent MX-2022015682-A (MX)
Title: Work method to design for thickening time by tailoring additives.
Inventor: JANDHYALA SIVA RAMA KRISHNA
IPC: C09K8/467
Filed: 2020-07-16
Abstract: A method of designing a cement slurry may include: (a) selecting at least a cement and concentration thereof, a water and concentration thereof, and one or more chemical additives and a concentration thereof such that a cement slurry formed from the cement, water, and the one or more chemical additives meet a density requirement; (b) calculating a thickening time of the cement slurry using a thickening time model; (c) comparing the thickening time of the cement slurry to a thickening time requirement, wherein steps (a)-(c) are repeated if the thickening time of the cement slurry does not meet or exceed the thickening time requirement, wherein the step of selecting comprises selecting concentrations and/or different chemical identities for the one or more chemical additives, cement, or water, or step (d) is performed if the thickening time of the cement slurry meets or exceeds the thickening time requirement; and (d) preparing the cement slurry.